Emergency Opioid Antagonist Products and Resources

The State of Florida, through the Department of Children and Families Substance Abuse and Mental Health division, is soliciting proposals to equip its Overdose Prevention Program with multiple formulations of Emergency Opioid Antagonist Products and associated resources. This procurement is conducted under Chapter 287 of the Florida Statutes and is identified by solicitation number DCF RFP 2627 020, with proposals due by November 10, 2026. The contract aims to secure life-saving opioid reversal agents and supporting materials for distribution statewide to combat the ongoing opioid crisis. Vendors must demonstrate the ability to supply approved formulations of emergency antagonists, ensuring product availability, compliance with state guidelines, and timely logistics across all regions of Florida. The procurement falls under NAICS code 51142300 and is managed by the Florida agency, with performance expected throughout the state. Sally Johns serves as the primary point of contact for inquiries, reachable via email and phone listed in the solicitation. The procurement does not specify a set-aside for any particular vendor category, meaning it is open to all qualified suppliers. Prospective bidders are directed to the online portal provided to access full details and submit proposals, with all awarded contracts supporting the Department’s mission to reduce opioid-related fatalities through accessible, high-quality emergency intervention tools.